Brief: GoodRx Holdings Q4 Adjusted Net Income USD 29 Million Vs. IBES Estimate USD 32 Million
25/02/2026 21:05
Feb 25 (Reuters) - GoodRx Holdings Q4 net income USD 5.4 million. Q4 revenue USD 194.8 million vs. IBES estimate USD 193.3 million Q4 adjusted EBITDA USD 65 million vs. IBES estimate USD 64.9 million Q4 adjusted EBITDA margin 33.4%
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million